4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
WOODLAND HILLS, Calif., May 25, 2020 -- (Healthcare Sales & Marketing Network) -- 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug ... Diagnostics, Radiology, FDA 4DMedical, COVID-19, asthma, COPD, cystic fibrosis, lung cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Asthma | Australia Health | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | COVID-19 | Cystic Fibrosis | Lung Cancer | Marketing | Pharmaceuticals | Radiology | Respiratory Medicine